[1] ZHOU Y, HUANG F, YANG Y, et al. Paraptosis-inducing nanomedicine overcomes cancer drug resistance for a potent cancer therapy[J]. Small, 2018, 14(7): 1702446. Doi: 10.1002/smll.201702446.
[2] DING Q, ZHANG W, CHENG C, et al. Dioscin inhibits the growth of human osteosarcoma by inducing G2/M-phase arrest, apoptosis, and GSDME-dependent cell death in vitro and in vivo[J]. J Cell Physiol, 2020, 235(3): 2911-2924.
[3] LIU J, CAI W, FANG X, et al. Virus-induced apoptosis and phosphorylation form of metacaspase in the marine coccolithophorid Emiliania huxleyi[J]. Arch Microbiol, 2018,200(3):413-422.
[4] JUNG S, CHOE S, WOO H, et al. Autophagic death of neural stem cells mediates chronic stress-induced decline of adult hippocampal neurogenesis and cognitive deficits[J]. Autophagy, 2020, 16(3): 512-530.
[5] NASS J, EFFERTH T. Insights into apoptotic proteins in chemotherapy: quantification techniques and informing therapy choice[J]. Expert Rev Proteomics, 2018,15(5):413-429.
[6] PFEFFER C M, SINGH A T K. Apoptosis: atarget for anticancer therapy[J]. Int J Mol Sci, 2018, 19(2): 448. Doi: 10.3390/ijms19020448.
[7] BLANK M, SHILOH Y. Programs for cell death: apoptosis is only one way to go[J]. Cell Cycle,2007,6(6):686-695.
[8] SPERANDIO S, DE BELL I, BREDESEN D E. An alternative, nonapoptotic form of programmed cell death[J]. Proc Natl Acad Sci USA,2000, 97(26):14376-14381.
[9] SUN Y, PENG Z L. Programmed cell death and cancer[J]. Postgrad Med J, 2009, 85(1001):134-140.
[10] HIRATA H, UTO-KONDO H, OGURA M, et al. Xanthohumol, a hop-derived prenylated flavonoid, promotes macrophage reverse cholesterol transport[J]. J Nutr Biochem, 2017, 47:29-34.
[11] CHEN Q, SONG S, WANG Z, et al. Isorhamnetin induces the paraptotic cell death through ROS and the ERK/MAPK pathway in OSCC cells[J]. Oral Dis, 2021, 27(2):240-250.
[12] KIST M, VUCIC D. Cell death pathways: intricate connections and disease implications[J]. EMBO J, 2021, 40(5):e106700. Doi: 10.15252/embj.2020106700.
[13] KAUFMANN S H, EARNSHAW W C. Induction of apoptosis by cancer chemotherapy[J]. Exp Cell Res, 2000, 256(1):42-49.
[14] BURY M, GIRAULT A, MEGALIZZI V, et al. Ophiobolin a induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity[J]. Cell Death Dis, 2013, 4(3):e561.Doi: 10.1038/cddis.2013.85.
[15] SPERANDIO S, POKSAY K, DE-BELLE I, et al. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix[J]. Cell Death Differ,2004, 11(10):1066-1075.
[16] WANG S, GUO Y, YANG C, et al. Swainsonine triggers paraptosis via ER stress and MAPK signaling pathway in rat primary renal tubular epithelial cells[J]. Front Pharmacol, 2021, 12:715285. Doi: 10.3389/fphar.2021.715285.
[17] PENG Y, GUO C, YANG Y, et al. Baicalein induces apoptosis of human cervical cancer HeLa cells in vitro[J]. Mol Med Rep, 2015, 11(3):2129-2134.
[18] ZHENG H, DONG Y, LI L, et al. Novel benzo[a]quinolizidine analogs induce cancer cell death through paraptosis and apoptosis[J]. J Med Chem, 2016, 59(10):5063-5076.
[19] RAIMONDI M, FONTANA F, MARZAGALLI M, et al. Ca²⁺ overload- and ROS-associated mitochondrial dysfunction contributes to delta-tocotrienol-mediated paraptosis in melanoma cells[J]. Apoptosis, 2021, 26(5-6):277-292.
[20] MI X Q, WANG C M, SUN C, et al. Xanthohumol induces paraptosis of leukemia cells through p38 mitogen activated protein kinase signaling pathway[J]. Oncotarget,2017, 8(19):31297-31304.
[21] YUMNAM S, PARK H S, KIM M K, et al. Hesperidin induces paraptosis like cell death in hepatoblastoma, HepG2 cells: involvement of ERK1/2 MAPK[J]. PLoS One,2014, 9(6):e101321. Doi: 10.1371/journal.pone.0101321.
[22] YUMNAM S, HONG G E, RAHA S, et al. Mitochondrial dysfunction and Ca²⁺ overload contributes to hesperidin induced paraptosis in hepatoblastoma cells, HepG2[J]. J Cell Physiol, 2016, 231(6):1261-1268.
[23] ZHU D, CHEN C, XIA Y, et al. A purified resin glycoside fraction from pharbitidis semen induces paraptosis by activating chloride intracellular channel-1 in human colon cancer cells[J]. Integr Cancer Ther, 2019, 18:1534735418822120. Doi: 10.1177/1534735418822120.
[24] WANG Y, ZHU X, YANG Z, et al. Honokiol induces caspase-independent paraptosis via reactive oxygen species production that is accompanied by apoptosis in leukemia cells[J]. Biochem Biophys Res Commun, 2013, 430(3):876-882.
[25] LIU X, GU Y, BIAN Y, et al. Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation[J]. Apoptosis, 2021, 26(3-4):195-208.
[26] FONTANA F, RAIMONDI M, MARZAGALLI M, et al. Mitochondrial functional and structural impairment is involved in the antitumor activity of delta-tocotrienol in prostate cancer cells[J]. Free Radic Biol Med,2020, 160:376-390.
[27] DAI C H, ZHU L R, WANG Y, et al. Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis[J]. J Cell Physiol, 2020, 236(6): 4538-4554.
[28] CHEN X, CHEN X M, ZHANG X, et al. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells[J]. Redox Biol, 2019, 21:101061. Doi: 10.1016/j.redox.2018.11.019.
[29] GARRIDO-ARMAS M, CORONA JC, ESCOBAR ML, et al. Paraptosis in human glioblastoma cell line induced by curcumin[J]. Toxicol In Vitro, 2018, 51:63-73.
[30] PANG H F, LI X X, ZHAO Y H, et al. Confirming whether novel rhein derivative 4a induces paraptosis-like cell death by endoplasmic reticulum stress in ovarian cancer cells[J]. Eur J Pharmacol, 2020, 886:173526. Doi: 10.1016/j.ejphar.2020.173526.
[31] YOKOI K, BALACHANDRAN C, UMEZAWA M, et al. Amphiphilic cationic triscyclometalated iridium(III) complex-peptide hybrids induce paraptosis-like cell death of cancer cells via an intracellular Ca²⁺-Dependent Pathway[J]. ACS Omeg, 2020, 5(12):6983-7001.
[32] DEMAIN A L, VAISHNAV P. Natural products for cancer chemotherapy[J]. Microb Biotechnol,2011, 4(6):687-699.
[33] WANG Y, WEN X, ZHANG N, et al. Small-molecule compounds target paraptosis to improve cancer therapy[J]. Biomed Pharmacother, 2019, 118:109203. Doi: 10.1016/j.biopha.2019.109203.
[34] GUO D L, ZHANG B G, LIU S Q, et al. Xanthohumol induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI3K/Akt/mTOR-kinase in human gastric cancer cells[J]. Biomed Pharmacother,2018,106:1300-1306.
[35] ZHAO X, JIANG K, LIANG B, et al. Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-kappaB/p53-apoptosis signaling pathway[J]. Oncol Rep, 2016, 35(2):669-675.
[36] LI F, YAO Y Y, HUANG H, et al. Xanthohumol attenuates cisplatin-induced nephrotoxicity through inhibiting NF-kappaB and activating Nrf2 signaling pathways[J]. Int Immunopharmacol,2018, 61:277-282.
[37] HU S, HUANG L, MENG L, et al. Isorhamnetin inhibits cell proliferation and induces apoptosis in breast cancer via Akt and mitogenactivated protein kinase kinase signaling pathways[J]. Mol Med Rep, 2015, 12(5):6745-6751.
[38] SUN J, SUN G, MENG X, et al. Isorhamnetin protects against doxorubicin-induced cardiotoxicity in vivo and in vitro[J]. PLoS One, 2013, 8(5):e64526. Doi: 10.1371/journal. pone. 0064 526.
[39] LEE C J, WILSON L, JORDAN M A, et al. Hesperidin suppressed proliferations of both human breast cancer and androgen-dependent prostate cancer cells[J]. Phytother Res, 2010, 24(Suppl 1):S15-S19.
[40] SUGAWARAF,STROBELG, STRANGERN, et al. Phytotoxins from the pathogenic fungi Drechslera maydis and Drechslera sorghicola[J]. Proc Natl Acad Sci USA, 1987, 84(10):3081-3085.
[41] KIM I Y, KWON M, CHOI M K, et al. Ophiobolin A kills human glioblastoma cells by inducing endoplasmic reticulum stress via disruption of thiol proteostasis[J]. Oncotarget, 2017, 8(63):106740-106752.
[42] CHENG L, CHEN Q, PI R, et al. A research update on the therapeutic potential of rhein and its derivatives[J]. Eur J Pharmacol, 2021, 899:173908. Doi: 10.1016/j.ejphar.2021.173908.
[43] LIU S, WANG J, SHAO T, et al. The natural agent rhein induces beta-catenin degradation and tumour growth arrest[J]. J Cell Mol Med, 2018, 22(1):589-599.
[44] LEE D, KIM I Y, SAHA S, et al. Paraptosis in the anti-cancer arsenal of natural products[J]. Pharmacol Ther, 2016, 162:120-133.
[45] XIONG Z, YUAN C, SHI J, et al. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress[J]. Theranostics, 2020, 10(25):11444-11461.
[46] HOTAMISLIGIL G S, DAVIS R J. Cell signaling and stress responses[J]. Cold Spring Harb Perspect Biol, 2016, 8(10):a006072. Doi: 10.1101/cshperspect.a006072.
[47] JIN J, MA Y, TONG X, et al. Metformin inhibits testosterone-induced endoplasmic reticulum stress in ovarian granulosa cells via inactivation of p38 MAPK[J]. Hum Reprod, 2020, 35(5):1145-1158.
[48] SHEN K, JOHNSON D W, VESEY D A, et al. Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies[J]. Cell Stress Chaperones, 2018, 23(3):317-334.
[49] APPENZELLER-HERZOG C, HALL MN. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling[J]. Trends Cell Biol, 2012, 22(5):274-282.
[50] NOROUZI S, MAJEED M, PIRRO M, et al. Curcumin as an adjunct therapy and microRNA modulator in breast cancer[J]. Curr Pharm Des, 2018, 24(2):171-177.
[51] YOON M J, KIM E H, LIM J H, et al. Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells[J]. Free Radic Biol Med, 2010, 48(5):713-726.
[52] YOON M J, KIM E H, KWON T K, et al. Simultaneous mitochondrial Ca²⁺ overload and proteasomal inhibition are responsible for the induction of paraptosis in malignant breast cancer cells[J]. Cancer Lett, 2012, 324(2):197-209.
[53] BRAVO R, GUTIERREZ T, PAREDES F, et al. Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics[J]. Int J Biochem Cell Biol, 2012, 44(1):16-20.
[54] CAO S S, KAUFMAN R J. Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease[J]. Antioxid Redox Signal, 2014, 21(3):396-413.
[55] YOON M J, LEEL A R, JEONG S A, et al. Release of Ca²⁺ from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells[J]. Oncotarget, 2014, 5(3):6816-6830.
[56] DHILLON A S, HAGAN S, RATH O, et al. MAP kinase signalling pathways in cancer[J]. Oncogene, 2007, 26(22):3279-3290.
[57] WAGNER E F, NEBREDA A R. Signal integration by JNK and p38 MAPK pathways in cancer development[J]. Nat Rev Cancer, 2009, 9(8):537-549.
[58] MARTINI M, DE SANTIS M C, BRACCINI L, et al. PI3K/AKT signaling pathway and cancer: an updated review[J]. Ann Med, 2014, 46(6):372-383.
[59] ALZAHRANI A S. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside[J]. Semin Cancer Biol,2019,59:125-132.
[60] PELUSO I, YARLA N S, AMBRA R, et al. MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents[J]. Semin Cancer Biol, 2019, 56:185-195.
[61] SUN Q, CHEN T, WANG X, et al. Taxol induces paraptosis independent of both protein synthesis and MAPK pathway[J]. J Cell Physiol,2010,222(2):421-432.